MTEX Mannatech Inc.

Mannatech Promotes Two Senior Members of Executive Team

Mannatech, Incorporated (NASDAQ: MTEX) a global health and wellness company committed to transforming lives to make a better world, promoted and added new responsibilities to a pair of senior members of its executive team, Landen Fredrick and Joel Bikman.

Fredrick, previously the Senior Vice President of Global Operations, was promoted to Chief Global Sales Officer and President, North America. He will coordinate worldwide sales activity and have P&L responsibility for all sales activity in the United States and Canada.

“I have seen, on a very personal level within my immediate family, the powerful health benefits of our products, particularly Ambrotose,” said Fredrick. “Having spent my first 6 years at Mannatech in sales and recently 6 years in operations, I am excited about this new role where I can utilize my experiences to help build our sales team of over 200,000 Associates into a formidable force in the exploding wellness industry.”

Mannatech CEO Al Bala said, “As we accelerate our sales pace, we must continue to build a pro-Associate culture inside our organization. Landen’s experience and passion for Mannatech and our life-changing products uniquely qualifies him to lead our sales growth around the world.”

Bikman, previously the Senior Vice President of Sales & Marketing, was given new, additional responsibilities over Supply Chain, Logistics and Facilities, and was promoted to Chief Operating and Marketing Officer. As such, he will continue to lead the company’s Marketing and Research and Development activities.

“It is an honor to work with the people and teams at Mannatech to develop and distribute these amazing products,” said Bikman. “I’m fortunate to work every day and do things that help make the world a healthier place. Within my family, too, I have personally seen the benefits of Ambrotose, and other Mannatech products, in improving health and wellness.”

Added Bala, “In today’s increasingly fast-paced business world, quick reaction time in the market is needed. Our rapid new product introductions and the supply chain transformation process have worked together to improve our ability to take our ideas and move them through the innovation pipeline and into the markets more quickly. Joel has proven his ability to lead and placing these additional responsibilities under him will help accelerate the process.”

Both promotions were announced on January 4, in a monthly company communications meeting, and were effective immediately.

EN
15/01/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Mannatech Inc.

 PRESS RELEASE

Mannatech Reports Financial Results for Third Quarter 2025

Mannatech Reports Financial Results for Third Quarter 2025 FLOWER MOUND, Texas, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2025. Third Quarter Results Net sales for the quarter ended September 30, 2025 were $29.2 million, as compared to $31.7 million for the same period in 2024, a decrease of $2.6 million, or 8.1%. On a Constant dollar basis (see Non-GAAP Measures, below) our net s...

 PRESS RELEASE

Mannatech Announces Appointment of Robert A. Toth as Vice Chairman of ...

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ) announced that on November 20, 2024, the Board of Directors of Mannatech, Incorporated (the “Board”) appointed Robert A. Toth to the Board where he will serve as Vice Chairman of the Board of Mannatech, Incorporated (the "Company") effective December 1, 2024. Mr. Toth will serve as a Class III director of the Board. Mr. Toth previously served on the Company's Board between March 2008 through May 31, 2023. Mr. Toth previously served as the Chairman of the Compensation and Stock Option Plan Committee, served on the Audit Committee, the Nominat...

 PRESS RELEASE

Mannatech Reports Financial Results for Third Quarter 2024

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2024. Third Quarter Highlights Net sales for the quarter ended September 30, 2024 were $31.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $0.9 million, or 2.5%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $0.4 million, or 1.2%, and unfavorable foreign exchange caused a $0.5 million decrease...

 PRESS RELEASE

Mannatech Reports Financial Results for Second Quarter 2024

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2024. Second Quarter Highlights Net sales for the quarter ended June 30, 2024 were $27.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $4.9 million, or 14.9%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $4.2 million, or 12.9%, and unfavorable foreign exchange caused a $0.7 million decrease ...

 PRESS RELEASE

Mannatech Announces Appointment of James Clavijo as Chief Financial Of...

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical c...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch